SPRAVATO® (esketamine) CIII Nasal Spray

A Breakthrough Treatment for Resistant Depression

SPRAVATO® is the first FDA-approved nasal spray for adults with treatment-resistant depression (TRD) or suicidal thoughts in MDD. Administered under medical supervision for rapid relief.

What is SPRAVATO?

SPRAVATO® is a prescription nasal spray used:

Limitations of Use:

Patients
0 k+
Doctors and Staff
0 +
Satisfaction
0 %
Years of Experience
0 +

Clinical Administration

How SPRAVATO® Works

SPRAVATO® (esketamine) is a non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist that:

Important Safety Information

Sedation, Dissociation, and Respiratory Depression:

1: SPRAVATO® may cause sleepiness (sedation), fainting, dizziness, spinning sensation, anxiety, or feeling disconnected from yourself, your thoughts, feelings, space and time (dissociation).
2: Breathing problems (respiratory depression and respiratory arrest) were observed.
3: Your healthcare provider must monitor you for at least 2 hours after administration.

Abuse and Misuse:

1: SPRAVATO® is a Schedule III controlled substance. There is a risk for abuse and misuse which may lead to physical or psychological dependence.
2: Your healthcare provider should check you for signs of abuse before and during treatment.

Suicidal Thoughts and Behaviors:

1: Antidepressants may increase suicidal thoughts/actions in patients ≤24 years, especially during initial treatment or dose changes.
2: Monitor all patients for worsening depression or emergent suicidal behaviors.

Serious side effects requiring immediate medical attention:

  • Blood pressure increases: May cause temporary spikes (monitored for ≥2 hours post-dose)

  • Suicidal thoughts/behaviors: Especially in patients ≤24 years

  • Respiratory depression: Rare cases of breathing problems/respiratory arrest

  • Cognitive impairment: Trouble thinking clearly

  • Bladder issues: Urinary frequency/pain

These typically occur right after dosing and resolve the same day.

Patient Resources

Because of risks of sedation, dissociation, respiratory depression, abuse and misuse, SPRAVATO is only available through a restricted program called the SPRAVATO REMS. SPRAVATO can only be administered at healthcare settings certified in the SPRAVATO REMS Program.

Pregnancy Exposure Registry

There is a pregnancy registry that monitors outcomes in women exposed to SPRAVATO during pregnancy. Healthcare providers can register patients by contacting:

Full Prescribing Information

Includes Boxed WARNINGS, Medication Guide, and complete safety data.

Get In Touch

Your inquiry will be replied to within 24 hours, and we respect your privacy.

For More Information Visit our Locations

Discover comprehensive psychiatric solutions at Veracity Psychiatry Solutions 

Our Insurances

Our Valuable Partners

Happy Clients

At Veracity Psychiatry Solutions, our joy is seeing clients thrive on their journey to renewed hope and improved mental health.

Frequently Asked Questions

Get Your Answers Here

Find Your Answers Here at Veracity Psychiatry Solutions – Your Guide to Mental Well-being.

At Veracity Psychiatry Solutions, we prioritize personalized approaches, integrating innovation and empathy to address your unique mental health needs

Our commitment lies in dedicated support, offering compassionate care and personalized guidance to facilitate positive, lasting change on your journey to better mental health.

Discover renewed hope with our caring team at Veracity Psychiatry Solutions, guiding you through every step of your journey and providing support on your path to improved mental health.

At Veracity Psychiatry Solutions, our success is defined by the happiness of our clients, witnessing their thriving journey to renewed hope and improved mental well-being.